Skip to content
mapperlab
← Dashboard
Stock

ALXN

ALEXION PHARMACEUTICALS INC
0 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
0
27 funds tracked
Ever held
5
Current + past
New this quarter
0
Exited this quarter
0

Marquee-fund ownership over time

Aug 14, 2013May 11, 2017May 14, 2019Nov 15, 2021
Now
0

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Maverick Capital 3× in & out+0%
Bridgewater Associates 7× in & out+0%
Duquesne Family Office+0%
Third Point+0%
Viking Global Investors 2× in & out+0%

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Maverick CapitalQ2 2021Q4 2021$0.00+0%
Bridgewater AssociatesQ1 2021Q4 2021$0.00+0%
Maverick CapitalQ2 2020Q1 2021$0.00+0%
Bridgewater AssociatesQ3 2019Q1 2020$0.00+0%
Bridgewater AssociatesQ1 2019Q2 2019$0.00+0%
Duquesne Family OfficeQ4 2018Q1 2019$0.00+0%
Bridgewater AssociatesQ3 2018Q4 2018$0.00+0%
Third PointQ3 2017Q1 2018$0.00+0%
Bridgewater AssociatesQ2 2017Q2 2018$0.00+0%
Viking Global InvestorsQ3 2015Q4 2015$0.00+0%
Maverick CapitalQ2 2015Q4 2015$0.00+0%
Bridgewater AssociatesQ1 2015Q3 2015$0.00+0%
Bridgewater AssociatesQ2 2014Q4 2014$0.00+0%
Viking Global InvestorsQ3 2013Q2 2015$0.00+0%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.